Erman Özdemir

Dr. Erman Özdemir

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2018 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
TSTuncay Sahutoglu
Tuncay Sahutoglu
OEOsman Erinc
Osman Erinc
FAFevzi Necati Avsar
Fevzi Necati Avsar
MBMeral Beyaz
Meral Beyaz
ABAziz Batu
Aziz Batu
ESElif Sahutoglu
Elif Sahutoglu

Verified
Journal Article
Open access
PDF file
EÖErman Özdemir
Erman Özdemir
PÖPINAR ÖZDEMİR
PINAR ÖZDEMİR
SYSerap Yadigar
Serap Yadigar
SYSerkan Yalin
Serkan Yalin
EPErgün Parmaksız
Ergün Parmaksız
MAMehmet Riza Altiparmak
Mehmet Riza Altiparmak
Background: Acute phosphate nephropathy (APN) is an underrecognized cause of acute kidney injury (AKI), typically associated with the use of oral sodium phosphate (OSP)-based bowel preparations. It is characterized by calcium phosphate crystal deposition within the renal tubules and may result in permanent renal impairment. Despite known risks, phosphate-containing solutions are still widely used without sufficient risk stratification. Methods: We retrospectively evaluated 517 native kidney biopsies performed in our nephrology clinic between 2017 and 2022. Among these, 12 patients with unexplained AKI and recent colonoscopy history were identified. In nine cases, non-specific tubular deposits on routine staining prompted further histochemical analysis. All had a history of recent OSP-based bowel cleansing. The use of von Kossa staining confirmed calcium phosphate deposition, consistent with APN. Results: Out of 517 kidney biopsies performed during the study period, 9 patients were diagnosed with APN based on histopathological findings following recent colonoscopy and OSP-based bowel cleansing. The mean age was 58.7 years, and three were female. Hypertension was present in seven patients, diabetes mellitus in three, and epilepsy in two; one patient had no comorbidities. Baseline renal function was normal (mean serum creatinine 0.86 mg/dL) and increased to 1.76 mg/dL at three months post-exposure. All biopsies revealed tubulointerstitial calcium phosphate deposits and interstitial inflammation; mesangial hypercellularity was observed in five cases, tubular atrophy in three, and acute tubular necrosis in one. All samples stained positive with von Kossa staining. Over time, all patients developed chronic kidney disease, and one progressed to end-stage renal disease requiring dialysis. Conclusions: In patients presenting with unexplained AKI and recent OSP-based bowel preparation, APN should be considered in the differential diagnosis. When routine histology is inconclusive, definitive diagnosis may require special histochemical staining. Risk-based restrictions on phosphate-containing agents are warranted to reduce preventable kidney injury.

14 May 2016 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
PDF file
EÖErman Özdemir
Erman Özdemir
PÖPınar Kutlutürk Özdemir
Pınar Kutlutürk Özdemir
EÖErdoğan Özdemir
Erdoğan Özdemir
MMMeral Meşe
Meral Meşe
EPErgün Parmaksız
Ergün Parmaksız
ZBZerrin Bicik Bahçebaşi
Zerrin Bicik Bahçebaşi

16 June 2025 in Hemodialysis International
Verified
Journal Article
Closed access
SYSerap Yadigar
Serap Yadigar
GHGülümser Sevgin Halil
Gülümser Sevgin Halil
PÖPINAR ÖZDEMİR
PINAR ÖZDEMİR
EÖErman Özdemir
Erman Özdemir
EGEzgi Gültekin Güner
Ezgi Gültekin Güner
MYMustafa Yıldız
Mustafa Yıldız

14 May 2016 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
ZBZerrin Bicik
Zerrin Bicik
MMMeral Mes¸e
Meral Mes¸e
EPErgün Parmaksiz
Ergün Parmaksiz
GBGuls¸aH Boz
Guls¸aH Boz
EÖErman Özdemir
Erman Özdemir
Introduction and Aims: Severity of vascular calcifiacation is in close relation with the pathology of chronic dialysis premorbid conditions. In this cross-section study we aimed to see the factors influencing the severity of vascular calcifications in continuous ambulatory peritoneal dialysis (CAPD) patients population.

13 June 2026 in Acta Medica Nicomedia
Verified
Journal Article
Closed access
EÖErman Özdemir
Erman Özdemir
Erdoğan ÖzdemirErdoğan Özdemir
Erdoğan Özdemir
SYSerap Yadigar
Serap Yadigar
PÖPINAR ÖZDEMİR
PINAR ÖZDEMİR
Objective: Rheumatoid arthritis (RA) is a systemic autoimmune disorder marked by chronic inflammation, with considerable heterogeneity in both disease trajectory and therapeutic response. The objective of this study is to assess whether RF and anti-CCP antibodies can serve as predictive markers for treatment outcomes in patients with rheumatoid arthritis undergoing anti-TNF-α therapy. Methods: This retrospective study analyzed 80 RA patients undergoing anti-TNF-α therapy (adalimumab, infliximab, or etanercept), stratified by serologic status: RF-positive alone (n = 27), anti-CCP-positive alone (n = 27), and double-seronegative (n = 26). Comprehensive disease activity assessment was performed using DAS28 scores, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels at baseline and following 12 months of treatment. Results: All groups showed significant improvement in ESR, CRP, and DAS28 scores after 12 months (p=0.001). No significant differences were observed between the groups in treatment response (p=0.587 for ESR, p=0.767 for CRP, p=0.999 for DAS28). Conclusion: RF and anti-CCP positivity did not significantly influence treatment response to anti-TNF therapy. Further studies with larger cohorts and quantitative antibody measurements are needed to confirm these findings.